Clinical Trials Insight: 700044143

Trial Profile

Clinical Trials Insight: 700044143

Phase of Trial: Phase III

Latest Information Update: 29 Apr 2009

At a glance

  • Drugs Cintredekin besudotox (Primary)
  • Indications Glioblastoma
  • Focus Registrational; Therapeutic Use
  • Sponsors INSYS Therapeutics, Inc
  • Most Recent Events

    • 29 Apr 2009 Regulary approval has not been granted for the confirmatory trial in India (see 700032156) by the Directorate General of Health Services -Office of Drugs Controller General (India). DCGI requested concurrent enrolment of patients in this trial in the USA.
    • 16 Oct 2008 Neopharm has signed a Cooperative Research and Development Agreement with the National Institute of Neurological Diseases and Stroke (NINDS), for research on a therapeutic agent for untreatable brain diseases in humans
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top